Imaging Solutions for leading industry,

academic research and technological innovation.

Boston Imaging Core Lab (BICL) is dedicated to enhancing the synergy between clinical excellence and cutting edge scientific research with a team of expert and highly specialized radiologists. BICL radiologists are among the leaders in musculoskeletal imaging with a strong focus on the application of MRI in osteoarthritis research. 

Paper written by BICL shareholders was featured by Dr. Ali Mobasheri, President of the OARSI in F1000Prime Editorial 
MRI-based screening for structural definition of eligibility in clinical DMOAD trials: Rapid OsteoArthritis MRI Eligibility Score (ROAMES).

Dr. Ali Mobasheri

Dr. Ali Guermazi Receives Esteemed Clinical Research Award At OARSI

Ali Guermazi, MD, PhD, President of BICL, Co-Founder of IWOAI, assistant dean of diversity and professor of radiology at BUSM, and vice chairman of academic affairs in the department of radiology at Boston Medical Center (BMC), is the recipient of Osteoarthritis Research Society International (ORSI) Clinical Research Award for his outstanding work in the field of imaging.

Guermazi is the first radiologist to receive this honor.

From theory to practice – the challenges of compositional MRI in osteoarthritis research

To date there is still no clinical application of compositional, also called “pre-morphologic“ MRI. Compositional techniques like T2 mapping, T1 rho or dGEMRIC are able to evaluate a tissues ultrastructure and has been used primarily for the assessment of cartilage in clinical studies and trials of knee osteoarthritis. Despite these technique being available on almost all clinical MRI systems, the interpretation of the data obtained is challenging.


In a current Editorial in Osteoarthritis & Cartilage BICL experts Drs. Roemer and Guermazi explain these current challenges and how these can be overcome to makes them eventually applicable in the clinic and also in clinical trials of knee osteoarhtritis. 

Web blast and in the Mainstream Media is Dr. Guermazi's findings on Steriod Injections of the Hip and Knee

Corticosteroid injections used to treat osteoarthritis pain in the hip and knee may be more dangerous than previously thought, according to a special report published in the journal Radiology. Researchers suggested that injection-associated risks like rapid progressive osteoarthritis, which eventually may lead to joint collapse, should be integrated into consent forms so that patients are aware of the potential risks associated with these treatments...

Imaging expertise . . .  Scientific excellence

BICL experts Drs. Guermazi and Roemer will be presenting at the upcoming 103rd Scientific Assembly an Annual Meeting of the Radiologic Society of North America, November 26 to December 1st at McCormick Place, Chicago, Il

In a featured session of “Osteoarthritis – Beyond the Basics” Dr. Roemer will give an invited lecture entitled “Radiographic Techniques and Evaluation”. He will focus on state of the art X-ray assessment, challenges encountered and how to overcome these. In the same session Dr. Guermazi will give an invited lecture entitled “Imaging of Synovitis and New Concepts in OA Imaging”.


Dr Guermazi will present the results of a “Novel treatment approach for osteoarthritis using intraarticular administration of allogeneic human chondrocytes expressing TGF-ß1 (TG-C) on structural progression of MRI features of knee”. 

BICL experts prominent at upcoming RSNA

Dr. Ali Guermazi was invited to the 1st OARSI Guangzhou Satellite Meeting. His presentation entitled “Why X-ray should not be used anymore as an endpoint in knee osteoarthritis clinical trials.

The congress venue will be the Kongresshaus Garmisch-Partenkirchen, Richard-Strauss-Platz 1, 82467 Garmisch-Partenkirchen, Germany.


The widely recognized international smyposium will include leaders in the field of radiology from the United States and Europe including renown speakers:

  • Dr. Hedvig Hricak, Sloan Kettering Memorial Center, New York

  • Dr. Donald Resnick, UCSD, San Diego

  • Dr. William Palmer, Massachusetts General Hospital, Harvard Medical School, Boston


Dr. Roemer will be covering the topic “Differential Diagnosis of bone marrow edema, subchondral fracture and osteonecrosis” a topic BICL leaders excel with in-depth experience and have gained international recognition. BICL’s core MSK team has focused intensely on this topic in recent years particularly in the context of clinical trials on aNGF compounds.

Dr. Frank Roemer, BICL CMO, speaking at the

- 18th MRI Symposium Garmisch -

The Bavarian Alps, January 18th, 2019

Dr. Frank Roemer and Dr. Michel Crema to speak at Munich Sports Imaging Course